Form 4: Accolade CEO Rajeev Singh Reports Stock Transactions
SEC Form 4
Accolade's CEO, Rajeev Singh, reports the conversion of restricted stock units and a sale of shares to cover tax obligations.
Summary
- Rajeev Singh, CEO of Accolade, Inc., reported transactions involving the company's common stock.
- On March 17, 2025, 933 shares were acquired through the conversion of Restricted Stock Units (RSUs).
- On March 18, 2025, 289 shares were sold at a price of $6.985 per share to cover tax withholding obligations related to the vesting and settlement of PRSUs.
- Following these transactions, Singh directly owns 829,090 shares of common stock and indirectly owns 651,619 shares through Avanti Holdings, LLC.
- The RSUs vest over four years from June 16, 2021, with 25% vesting on the first anniversary and the remainder vesting monthly thereafter.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing showing stock transactions related to compensation. The sale of shares to cover taxes is a common practice.
Positives
- The vesting of RSUs indicates a continued investment in the company by the CEO.
Negatives
- The sale of shares, although for tax obligations, could be perceived negatively by some investors.
Risks
- Future stock sales by the CEO could put downward pressure on the stock price.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of the RSUs implies continued service by the CEO.
Industry Context
This filing is a routine disclosure related to insider trading and is a standard practice for publicly traded companies. It provides transparency regarding the transactions of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice across all publicly listed companies, including Accolade's competitors like Teladoc Health (TDOC) and Livongo (now part of Teladoc).
- The vesting schedules and terms of RSUs are generally comparable to those offered by other companies in the tech and healthcare sectors to incentivize and retain key executives.
Stakeholder Impact
- The transactions could have a minor impact on shareholders depending on their perception of insider trading activity.
Key Dates
| Date | Description |
|---|---|
| June 16, 2021 | June 2021 Vesting Commencement Date for Restricted Stock Units |
| 03/17/2025 | Conversion of Restricted Stock Units into Common Stock |
| 03/18/2025 | Sale of Common Stock to cover tax withholding obligations |
| 03/19/2025 | Date of signature for the Form 4 filing |
Keywords
Accolade, Rajeev Singh, stock, RSU, CEO, ACCD, Form 4, shares, transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.